At a glance
Overview
This monthly dashboard expands on the weekly COVID-19, flu, and RSV data available. It allows users to take a deeper dive into attitudes and behaviors associated with COVID-19, flu, and RSV vaccine uptake by a comprehensive set of demographic characteristics, behavioral and social drivers of vaccination, and barriers to vaccination.
Methods
Vaccination coverage estimates among adults 18 years and older are based on data from CDC's National Immunization Survey–Adult COVID Module. Estimates of vaccination coverage are based on respondent self-report. Estimates of vaccination coverage on this dashboard may vary from estimates on the weekly dashboard; weekly estimates are derived from compiling interview data from all prior weeks, while monthly estimates are derived only from interviews conducted that month.
Data Summary
- As of September 2024, 4.7% of adults 18+ in the U.S. have received a 2024–25 COVID-19 vaccine and 10.0% have received a 2024–25 flu vaccine.
- Coverage is highest among adults 65+ (11.5% and 17.7%, respectively).
- Coverage is highest among adults 65+ (11.5% and 17.7%, respectively).
- Concern about disease, confidence in vaccine safety, and confidence in the importance of the vaccine to prevent disease continue to be drivers of vaccination.
- Adults who expressed moderate to high concern about getting COVID-19 disease are more likely to have received a 2024–25 COVID-19 vaccine compared with adults who express little to no concern (7.7% vs. 2.8%). Adults who consider the vaccines safe and who consider the vaccines important to protect them are also more likely to have received the 2024–25 COVID-19 vaccine (8.5% vs. 0.9% and 7.4% vs. 0.2%, respectively).
- Adults who expressed moderate to high concern about getting flu are more likely to have received a 2024–25 flu vaccine compared with adults who express little to no concern (13.2% vs. 8.6%). Adults who consider the vaccines safe and who consider the vaccines important to protect them are also more likely to have received the 2024–25 vaccine (13.6% vs. 4.7% and 13.4% vs. 2.1%, respectively).
- Adults who expressed moderate to high concern about getting COVID-19 disease are more likely to have received a 2024–25 COVID-19 vaccine compared with adults who express little to no concern (7.7% vs. 2.8%). Adults who consider the vaccines safe and who consider the vaccines important to protect them are also more likely to have received the 2024–25 COVID-19 vaccine (8.5% vs. 0.9% and 7.4% vs. 0.2%, respectively).
- Coverage is higher among people whose healthcare provider recommended the vaccine vs. people who did not receive a recommendation for both COVID-19 (12.3% vs. 3.4%) and flu (18.2% vs. 6.5%).
- The percent of adults reporting a healthcare provider had recommended vaccination since July 1, 2024 was 15.6% for COVID-19 and 28.4% for influenza vaccination.
- Few (6.3%) adults reported it would be somewhat or very difficult to get a COVID-19 vaccine.